您的位置: 首页 > 农业专利 > 详情页

EGR1 TARGETING MOLECULES FOR THE TREATMENT OF INFLAMMATORY AND HYPERPROLIFERATIVE CONDITIONS
专利权人:
The Medical Research; Infrastructure and Health Services Fund of the Tel Aviv Medical Center
发明人:
Ofer SARIG,Eli SPRECHER
申请号:
US15569407
公开号:
US20180289728A1
申请日:
2016.04.26
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A method of treating an inflammation or a hyperproliferative disease in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount of a compound selected from the group consisting of:a compound represented by Formula I:or a pharmaceutically acceptable salt thereof,a compound represented by Formula II:and a compound represented by Formula III:wherein the variables in Formulae I, II and III are as defined in the specification.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充